Factor X Activator for Hemophilia Patients with Inhibitors: A Phase 1, First-in-Human, Multi-Center, and Open-Label Trial

被引：0
|
作者：
Liu, Wei [1 ,2 ]
Xue, Feng [1 ,2 ]
Fu, Rongfeng [1 ,2 ]
Ding, Bingjie [3 ,4 ]
Li, Mengjuan [1 ,2 ]
Sun, Ting [1 ,2 ]
Chen, Yunfei [1 ,2 ]
Liu Xiaofan [1 ,2 ]
Ju, Mankai [1 ,2 ]
Dai, Xinyue [1 ,2 ]
Wu, Quanrui [5 ]
Zhou, Zan [5 ]
Wang, Xiaomin [5 ]
Yu, Jiaojiao [5 ]
Zhou, Hu [3 ,4 ]
Yang, Renchi [1 ,2 ]
Zhang, Lei [1 ,2 ]
机构：
[1] Chinese Acad Med Sci, State Key Lab Expt Hematol, Natl Clin Res Ctr Blood Dis, Haihe Lab Cell Ecosyst,Inst Hematol, Tianjin, Peoples R China
[2] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China
[3] Zhengzhou Univ, Affiliated Canc Hosp, Dept Hematol, Zhengzhou, Peoples R China
[4] Zhengzhou Univ, Henan Canc Hosp, Hemostasis & Thrombosis Diagnost Engn Res Ctr Hen, Zhengzhou, Peoples R China
[5] Staidson Beijing Biopharmaceut Co Ltd, Beijing, Peoples R China
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-159948
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8474 / 8475
页数：2
相关论文
共 50 条
  • [41] Long-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study
    Lugogo, Njira
    Domingo, Christian
    Chanez, Pascal
    Leigh, Richard
    Gilson, Martyn J.
    Price, Robert G.
    Yancey, Steven W.
    Ortega, Hector G.
    CLINICAL THERAPEUTICS, 2016, 38 (09) : 2058 - 2070
  • [42] Recombinant Porcine Factor VIII in Patients with Congenital Hemophilia a with Inhibitors Undergoing Surgery: Phase 3, Multicenter, Single Arm, Open-Label Study
    Pfrepper, Christian
    Radossi, Paolo
    Windyga, Jerzy
    Kavakli, Kaan
    Schutgens, Roger E. G.
    Sarper, Nazan
    Baptista, Jovanna
    Badejo, Kayode
    Ewenstein, Bruce
    Jain, Nisha
    BLOOD, 2021, 138
  • [43] SAFETY AND PRELIMINARY EFFICACY AND PHARMACOKINETICS OF INTRAPERITONEAL VS-01 INFUSIONS IN PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS: A FIRST-IN-HUMAN, OPEN-LABEL, PHASE 1b CLINICAL TRIAL
    Uschner, Frank Erhard
    Schulz, Martin
    Tyc, Olaf
    Ferstl, Philip
    Stoffers, Philipp
    Erasmus, Hans-Peter
    Masseli, Johannes
    Peiffer, Kai-Henrik
    Finkelmeier, Fabian
    Pathil, Anita
    Bojunga, Joerg
    Biguenet, Sophie
    Zeuzem, Stefan
    Kabbaj, Meriam
    Trebicka, Jonel
    HEPATOLOGY, 2021, 74 : 139A - 139A
  • [44] Robot-assisted approach to cervical cancer (RACC): an international multi-center, open-label randomized controlled trial
    Falconer, Henrik
    Palsdottir, Kolbrun
    Stalberg, Karin
    Dahm-Kahler, Pernilla
    Ottander, Ulrika
    Lundin, Evelyn Serreyn
    Wijk, Lena
    Kimmig, Rainer
    Jensen, Pernille Tine
    Eriksson, Ane Gerda Zahl
    Maenpaa, Johanna
    Persson, Jan
    Salehi, Sahar
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (06) : 1072 - 1076
  • [45] Extension study to the open-label, multi-center, expanded access study of everolimus in patients with advanced neuroendocrine tumors
    Doerffel, Y.
    Kullmann, F.
    Lammert, F.
    Quietzsch, D.
    Schoefl, C.
    Schuppert, F.
    Weber, M.
    Baum, V.
    Berndt, I.
    Weiss, C.
    Lahner, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 237 - +
  • [46] Effectiveness of quetiapine in patients with bipolar I and II depression: A multi-center, prospective, open-label, observational study
    Jeong, J. -H.
    Bahk, W. -M.
    Woo, Y. S.
    Seo, H. -J.
    Hong, S. -C.
    Jon, D. -I.
    Cho, H. -S.
    Yoo, S. Y.
    Min, K. J.
    Yoon, B. -H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 126 - 126
  • [47] AN OPEN-LABEL, MULTI-CENTER, RANDOMIZED, SUPERIORITY TRIAL OF VONOPRAZAN VERSUS ESOMEPRAZOLE AS PART OF FIRST-LINE TRIPLE THERAPY FOR HELICOBACTER PYLORI INFECTION
    Tamaki, Hiroyuki
    Noda, Teruyo
    Morita, Masahiro
    Omura, Akina
    Kubo, Atsushi
    Ogawa, Chikara
    Matsunaka, Toshihiro
    Shibatoge, Mitsushige
    GASTROENTEROLOGY, 2019, 156 (06) : S89 - S89
  • [48] Trial in Progress: An Open-Label, Multi-Center, First in Human, Phase 1/2a Trial to Evaluate the Safety and Preliminary Efficacy of Autologous Tolerogenic Dendritic Cells Ex Vivo Loaded with Recombinant Factor VIII (FVIII) in Adults with Congenital Hemophilia a (HA) with Neutralizing Antibodies to FVIII and Having Failed Immune Tolerance Induction (ITI)
    Astermark, Jan
    Ljung, Rolf
    Karlsson, Eva
    Xie, Hanjing
    BLOOD, 2022, 140 : 12733 - 12734
  • [49] A phase II open-label study evaluating the hemostatic activity, pharmacokinetics and safety of recombinant porcine factor VIII (OBI-1) in hemophilia A patients with inhibitors directed against human FVIII
    Mahlangu, J.
    Andreeva, T.
    Macfarlane, D.
    Reding, M.
    Walsh, C.
    Ewing, N.
    Kessler, M.
    Kempton, C.
    Mathew, P.
    Plyushch, O.
    Shapiro, A.
    St-Louis, J.
    Warrier, I.
    Hoots, K.
    HAEMOPHILIA, 2008, 14 : 15 - 16
  • [50] Efficacy of Helicobacter pylori eradication on functional dyspepsia in Korean patients; A prospective, multi-center, randomized, open-label, parallel design clinical trial
    Kim, Sung Eun
    Kim, Nayoung
    Park, Kyung Sik
    Lee, Ju Yup
    Kim, Hyun Jin
    Park, Seon Mee
    Baik, Gwang Ho
    Shim, Ki-Nam
    Oh, Jung Hwan
    Choi, Suck Chei
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 68 - 68
12345